[
    [
        {
            "time": "",
            "original_text": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
            "features": {
                "keywords": [
                    "公募基金",
                    "持股市值",
                    "创新高",
                    "社保",
                    "加仓",
                    "周期股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "周期股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "中信建投：维持智飞生物(300122.SZ)“买入”评级 业绩符合预期 重磅品种放量可期",
            "features": {
                "keywords": [
                    "中信建投",
                    "智飞生物",
                    "买入评级",
                    "业绩",
                    "重磅品种",
                    "放量"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中信建投：维持智飞生物(300122.SZ)“买入”评级 业绩符合预期 重磅品种放量可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药行业：疫苗板块高景气有望延续",
            "features": {
                "keywords": [
                    "医药行业",
                    "疫苗板块",
                    "高景气",
                    "延续"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业：疫苗板块高景气有望延续",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物上市公司2021年三季报小结：板块业绩增速继续稳定 自下而上寻找专精特新",
            "features": {
                "keywords": [
                    "医药生物",
                    "上市公司",
                    "三季报",
                    "板块业绩",
                    "增速稳定",
                    "专精特新"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物上市公司2021年三季报小结：板块业绩增速继续稳定 自下而上寻找专精特新",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]